Department of Radiotherapy, Policlinico Umberto I "Sapienza" University of Rome, Viale Regina Elena 326, 00161, Rome, Italy.
Department of Radiotherapy, Policlinico Umberto I "Sapienza" University of Rome, Viale Regina Elena 326, 00161, Rome, Italy.
Crit Rev Oncol Hematol. 2018 Aug;128:82-87. doi: 10.1016/j.critrevonc.2018.06.002. Epub 2018 Jun 12.
Renal cell carcinoma (RCC) is classically regarded as extremely resistant to classical fractionated radiation therapy (RT). Nowadays, there is convincing data supporting RCC radiosensitivity to high fraction doses, which may represent an ideal issue for new treatment strategies in primary and oligometastatic RCC disease. This review discusses the role of RT in RCC and its potential therapeutic scenario focusing on the most interesting clinical trials.
肾细胞癌 (RCC) 通常被认为对经典的分割放疗 (RT) 具有极强的抵抗力。如今,有令人信服的数据支持 RCC 对高分割剂量的辐射敏感性,这可能是原发性和寡转移 RCC 疾病新治疗策略的理想问题。本综述讨论了 RT 在 RCC 中的作用及其潜在的治疗方案,重点介绍了最有趣的临床试验。